Status:
WITHDRAWN
Treating Stress Urinary Incontinence: Laparoscopic Obturator Urethropexy vs Burch Urethropexy
Lead Sponsor:
Mount Sinai Hospital, Canada
Conditions:
Stress Urinary Incontinence
Eligibility:
FEMALE
18+ years
Phase:
NA
Brief Summary
Stress urinary incontinence (SUI) is a highly prevalent concern within the female population. Although mid urethral slings (MUS) have been the first line treatment for SUI for almost twenty years, due...
Eligibility Criteria
Inclusion
- At least 18 years of age and be able to read and write English
- Women with symptomatic SUI, stress predominant mixed urinary incontinence symptoms confirmed on urodynamic study (UDS), or occult SUI (i.e. demonstrable urinary leakage on preoperative urodynamics with prolapse reduction in a patient without overt urinary incontinence symptoms), including women undergoing concomitant pelvic organ prolapse (POP) surgery or MUS sling removal
Exclusion
- Known or suspected disease that affects bladder function (e.g. multiple sclerosis, Parkinson disease), including a known diagnosis of voiding dysfunction
- Pregnancy
- Desired fertility
- Urethral diverticulum
- History of radical pelvic surgery or pelvic radiation therapy
- Current chemotherapy or radiation therapy for malignancy
Key Trial Info
Start Date :
January 1 2023
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
October 1 2033
Estimated Enrollment :
Patients enrolled
Trial Details
Trial ID
NCT04133935
Start Date
January 1 2023
End Date
October 1 2033
Last Update
November 22 2021
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.